Andreas Daniel Hartkopf (Andreas Hartkopf, Andreas D Hartkopf)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Metastatic Breast Cancer

Physical Activity

Top Venues

International journal of molecular sciences

Archives of gynecology and obstetrics

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Dominik Dannehl, Alexandra von Au, Tobias Engler, Léa Louise Volmer, Raphael Gutsfeld, Johannes Felix Englisch, Markus Hahn, Sabine Hawighorst-Knapstein, Ariane Chaudhuri, Armin Bauer, Markus Wallwiener, Florin-Andrei Taran, Diethelm Wallwiener, Sara Yvonne Brucker, Stephanie Wallwiener, Andreas Daniel Hartkopf, Tjeerd Maarten Hein Dijkstra
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020. Cancers 16 (8) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Dominik Dannehl, Alexandra von Au, Tobias Engler, Léa Louise Volmer, Raphael Gutsfeld, Johannes Felix Englisch, Markus Hahn, Sabine Hawighorst-Knapstein, Ariane Chaudhuri, Armin Bauer, Markus Wallwiener, Florin-Andrei Taran, Diethelm Wallwiener, Sara Yvonne Brucker, Stephanie Wallwiener, Andreas Daniel Hartkopf, Tjeerd Maarten Hein Dijkstra
Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020. Cancers 16 (8) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Hannes Armbruster, Tilman Schotte, Isabell Götting, Mathis Overkamp, Massimo Granai, Lea Louise Volmer, Veronika Bahlinger, Sabine Matovina, André Koch, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Sara Yvonne Brucker, Irina Bonzheim, Falko Fend, Annette Staebler, Ivonne-Aidee Montes-Mojarro
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations. Virchows Archiv : an international journal of pathology (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Léa Louise Volmer, Dominik Dannehl, Sabine Matovina, Florin-Andrei Taran, Christina Barbara Walter, Markus Wallwiener, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler
Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer. International journal of molecular sciences 25 (11) (2024)
Stefan Lukac, Davut Dayan, Visnja Fink, Elena Leinert, Andreas Daniel Hartkopf, Kristina Veselinovic, Wolfgang Janni, Brigitte Rack, Kerstin Pfister, Benedikt Heitmeir, Florian K Ebner
Evaluating ChatGPT as an adjunct for the multidisciplinary tumor board decision-making in primary breast cancer cases. Archives of gynecology and obstetrics (2023)
Cansu E Önder, Teresa J Ziegler, Ronja Becker, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Tobias Engler, André Koch
Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer. Cancers 15 (14) (2023)
Dorothee Jakob, Claudia Schmoor, Raphael Reuten, Marie Louise Frevert, Dominik Dannehl, Lina Jansen, Silke Hermann, Peter Jungmann, Andreas Daniel Hartkopf, Ingolf Juhasz-Böss, Florin-Andrei Taran
Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer-A Population-Based Study. Cancers 15 (23) (2023)
Dominik Dannehl, Tobias Engler, Léa Louise Volmer, Christian Martin Tegeler, Julia Fusshoeller, Emma Gabrysch, Kenneth Eissler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Ines Gruber, Fabienne Schochter, Kerstin Pfister, Kristina Veselinovic, Elena Leinert, Brigitte Rack, Visnja Fink, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Henning Schäffler
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers. Cancers 15 (15) (2023)
Cansu E Önder, Moustafa Moustafa-Oglou, Sarah M Schroeder, Andreas Daniel Hartkopf, André Koch, Christian Martin Seitz
Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis. Cancers 16 (1) (2023)
Polina Kaidun, Samuel J Holzmayer, Sarah M Greiner, Anna Seller, Christian Martin Tegeler, Ilona Hagelstein, Jonas Mauermann, Tobias Engler, André Koch, Andreas Daniel Hartkopf, Helmut R Salih, Melanie Märklin
Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer. International journal of molecular sciences 24 (17) (2023)
Henning Schäffler, Franziska Mergel, Kerstin Pfister, Stephan Lukac, Angelina Fink, Kristina Veselinovic, Brigitte Rack, Visnja Fink, Elena Leinert, Moritz Dimpfl, Alexander Englisch, Christian Martin Tegeler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Léa Louise Volmer, Tobias Engler, Marie Louise Frevert, Florin-Andrei Taran, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Dominik Dannehl
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers. International journal of molecular sciences 24 (22) (2023)
Florin-Andrei Taran, Jana Pasternak, Annette Staebler, Annika Rohner, Felix Neis, Tobias Engler, Ernst Oberlechner, Birgitt Schönfisch, Ingolf Juhasz-Böss, Andreas Daniel Hartkopf, Sara Yvonne Brucker, Christina Barbara Walter
Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center. Cancers 15 (16) (2023)
Léa L Volmer, Cansu E Önder, Barbara Volz, Anjali R Singh, Sara Yvonne Brucker, Tobias Engler, Andreas Daniel Hartkopf, André Koch
Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients. International journal of molecular sciences 24 (18) (2023)
Cansu E Önder, Moustafa Moustafa-Oglou, Sarah M Schroeder, Andreas Daniel Hartkopf, André Koch, Christian Martin Seitz
Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis. Cancers 16 (1) (2023)
Juliane Nees, Simon Schafferer, Baowen Yuan, Quiqong Tang, Matthias Scheffler, Andreas Daniel Hartkopf, Michael Golatta, Andreas Schneeweiß, Barbara Burwinkel, Markus Wallwiener
How previous treatment changes the metabolomic profile in patients with metastatic breast cancer. Archives of gynecology and obstetrics 306 (6) (2022)
Joachim Graf, Nina Sickenberger, Katharina Brusniak, Lina Maria Matthies, Thomas Maximilian Deutsch, Elisabeth Simoes, Claudia Plappert, Lucia Keilmann, Andreas Daniel Hartkopf, Christina Barbara Walter, Markus Hahn, Tobias Engler, Stephanie Wallwiener, Florian Schuetz, Peter Andreas Fasching, Andreas Schneeweiß, Sara Yvonne Brucker, Markus Wallwiener
Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial. Journal of medical Internet research 24 (2) (2022)
Peter Andreas Fasching, Siddhartha Yadav, Chunling Hu, Marius Wunderle, Lothar Häberle, Steven N Hart, Matthias Rübner, Eric C Polley, Kun Y Lee, Rohan D Gnanaolivu, Peyman Hadji, Hanna Huebner, Hans Tesch, Johannes Ettl, Friedrich Overkamp, Michael Patrick Lux, Arif Bülent Ekici, Bernhard Volz, Sabrina Uhrig, Diana Lüftner, Markus Wallwiener, Volkmar Mueller, Erik Belleville, Michael Untch, Hans-Christian Kolberg, Matthias W Beckmann, André Reis, Arndt Hartmann, Wolfgang Janni, Pauline Wimberger, Florin-Andrei Taran, Tanja N Fehm, Diethelm Wallwiener, Sara Y Brucker, Andreas Schneeweiß, Andreas Daniel Hartkopf, Fergus J Couch
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Franziska Hauth, Barbara Gehler, Andreas Michael Nieß, Katharina Fischer, Andreas Toepell, Vanessa Heinrich, Inka Roesel, Andreas Peter, Mirjam Renovanz, Andreas Daniel Hartkopf, Andreas Stengel, Daniel Zips, Cihan Gani
An Activity Tracker-Guided Physical Activity Program for Patients Undergoing Radiotherapy: Protocol for a Prospective Phase III Trial (OnkoFit I and II Trials). JMIR research protocols 10 (9) (2021)
Katharina Brusniak, Manuel Feisst, Linda Sebesteny, Andreas Daniel Hartkopf, Joachim Graf, Tobias Engler, Andreas Schneeweiß, Markus Wallwiener, Thomas Maximilian Deutsch
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study. JMIR cancer 7 (4) (2021)
Johanna Naskou, Yvonne Beiter, Ruan van Rensburg, Ellen Honisch, Martina Rudelius, Martin Schlensog, Julia Gottstein, Larissa Walter, Elena I Braicu, Jalid Sehouli, Silvia Darb-Esfahani, Annette Staebler, Andreas Daniel Hartkopf, Sara Brucker, Diethelm Wallwiener, Ines Beyer, Dieter Niederacher, Tanja Fehm, Markus F Templin, Tanja N Fehm
EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM. Molecular cancer research : MCR 18 (2) (2019)